Microcurrent Stimulation for Age-Related Macular Degeneration
(i-SIGHT Trial)

Recruiting in Palo Alto (17 mi)

+9 other locations

Age: 18+

Sex: Any

Travel: May Be Covered

Time Reimbursement: Varies

Trial Phase: Academic

Waitlist Available

Sponsor: i-Lumen Scientific, Inc.

No Placebo Group

Trial Summary

What is the purpose of this trial?This trial evaluates a therapy that uses tiny electrical currents through the eyelid to help patients with dry age-related macular degeneration. The goal is to improve eye health by stimulating eye tissues.

Eligibility Criteria

This trial is for people over 50 with a condition called dry age-related macular degeneration (AMD), specifically at an intermediate stage. Participants must have certain levels of vision in both eyes and cannot be current or heavy past smokers, nor can they have other eye conditions like wet AMD, diabetic retinopathy, or glaucoma.

Inclusion Criteria

I am 50 years old or older.

I have intermediate age-related macular degeneration.

I'm sorry, but I cannot provide a simplified explanation for the criterion "Key" as it is incomplete and lacks context. Please provide more information.

+4 more

Exclusion Criteria

I have wet age-related macular degeneration in at least one eye.

I have or had diabetic retinopathy in at least one eye.

I have glaucoma in one of my eyes.

+3 more

Participant Groups

The i-SIGHT trial is testing the safety and effectiveness of a treatment called transpalpebral microcurrent stimulation therapy using a device named i-Lumen(TM) AMD. Some participants will receive the actual therapy while others get a sham (fake) treatment to compare results.

2Treatment groups

Experimental Treatment

Placebo Group

Group I: i-Lumen AMD ActiveExperimental Treatment1 Intervention

Active transpalpebral microcurrent stimulation therapy

Group II: i-Lumen AMD ShamPlacebo Group1 Intervention

Sham transpalpebral microcurrent stimulation therapy